Project Number 5P01AG014449-20 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Synaptic, Cholinergic and Amyloid Alterations in Mild Cognitive Impairment Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 7. Circuits and Synapses a. Synaptic Plasticity and Synaptic Dysfunction Researcher and Organization Principal Investigator IKONOMOVIC, MILOS D Principal Investigator First Name IKONOMOVIC Principal Investigator Last Name MILOS D Awardee Organization ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-11-066: NIA PROGRAM PROJECT APPLICATIONS (P01) FY Overall Cost $288,168 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official OPANASHUK, LISA A Related Resources Repository [AlzPED] Intravenous immunoglobulin reduces tau pathology and preserves neuroplastic gene expression in the 3xTg mouse model of Alzheimer's disease
